COMMUNIQUÉS West-GlobeNewswire

Helsinn Group announces agreement to acquire worldwide rights to Valchlor/Ledaga, an approved and marketed alkylating agent for topical treatment of mycosis fungoides type cutaneous T-cell lymphoma

21/03/2018 - 09:00

Helsinn Group announces agreement to acquire worldwide rights to Valchlor ® /Ledaga ® - an approved and marketed alkylating agent for the topical treatment of mycosis fungoides- type cutaneous T- cell lymphoma, a rare [...]

Notice Convening the Annual General Meeting

21/03/2018 - 08:54

March 21, 2018 Announcement no. 6 Notice Convening the Annual General Meeting The Board of Directors hereby convenes the Annual General Meeting of BioPorto A/S: April 13, 2018, at 3.00 pm (CET), At the Company’s address [...]

Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics

21/03/2018 - 08:15

VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) ( “ Veritas ” or the “Company”) is pleased to announce the Company has completed the 100% [...]

DBV Technologies Announces Pricing of $150.0 million (€122.5 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares

21/03/2018 - 08:01

Montrouge, France, March 21, 2018 DBV Technologies Announces Pricing of $150.0 million ( € 122.5 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares DBV Technologies (the " [...]

DBV Technologies annonce le prix de son offre globale d'actions ordinaires, pouvant prendre la forme d'American Depositary Shares, pour un montant total de 150 millions de dollars américains

21/03/2018 - 08:01

Montrouge, France, 21 Mars 2018, 8h00 CET DBV Technologies annonce le prix de son offre globale d'actions ordinaires, pouvant prendre la forme d'American Depositary Shares, pour un montant total de 150 millions de [...]

Financière de Tubize SA: Convening of the ordinary and extraordinary general meetings of shareholders of the 25th of April 2018

21/03/2018 - 08:01

Financière de Tubize SA/NV Allée de la Recherche 60 1070 Brussels BE 0403.216.429 www.financiere-tubize.be CONVENING OF THE ORDINARY AND EXTRAORDINARY GENERAL MEETINGS OF SHAREHOLDERS OF 25 APRIL 2018 The shareholders [...]

Financière de Tubize SA: Convocation de l'assemblée générale ordinaire et de l'assemblée générale extraordinaire des actionnaires du 25 avril 2018

21/03/2018 - 08:01

Financière de Tubize SA Allée de la Recherche 60 1070 Bruxelles BE 0403.216.429 www.financiere-tubize.be CONVOCATION DE L'ASSEMBLEE GENERALE ORDINAIRE DES ACTIONNAIRES ET DE L'ASSEMBLEE GENERALE EXTRAORDINAIRE DU 25 [...]

MHRA Grants UK Patients Early Access to Akcea Therapeutics’ Volanesorsen for Familial Chylomicronaemia Syndrome (FCS)

21/03/2018 - 08:00

LONDON, March 21, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics United Kingdom (UK) Ltd today announced that volanesorsen has been granted a positive scientific opinion through the Early Access to Medicines Scheme (EAMS) [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

21/03/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 21 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Bone Therapeutics SA : Information on the total number of voting rights and shares

21/03/2018 - 07:01

Regulated information Information on the total number of voting rights and shares Gosselies, Belgium, 21 March 2018, 7am CET - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company [...]

Bone Therapeutics SA : Information relative au nombre total de droits de vote et d'actions

21/03/2018 - 07:01

Information réglementée Information relative au nombre total de droits de vote et d'actions Gosselies, Belgique, le 21 mars 2018, 7h00 CET - BONE THERAPEUTICS (code Euronext Bruxelles et Paris: BOTHE), société de [...]

Sorrento Therapeutics CEO Dr Ji to Present at Needham 17th Annual Healthcare Conference on 03/27/18

21/03/2018 - 04:03

SAN DIEGO, March 20, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that Dr Ji will present at the Needham 17 th Annual Healthcare Conference in NYC on March 27 th [...]

XORTX Announces Issuance of Stock Options

21/03/2018 - 02:24

CALGARY, Alberta, March 20, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney [...]

scPharmaceuticals Inc. Reports Fourth Quarter 2017 Financial Results

21/03/2018 - 00:22

Announced $147.7 Million of equity capital raising in 2017; Completed an Initial Public Offering; Advances towards FUROSCIX™ PDUFA date BURLINGTON, Mass., March 20, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. ( [...]

DiaMedica Therapeutics Announces Closing of Private Placement

20/03/2018 - 22:40

MINNEAPOLIS, March 20, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ”) (TSX-V: DMA ) (OTCQB:DMCAF) is pleased to announce the successful completion of the first closing of a private placement for [...]

Immunovaccine Announces Year-End 2017 Financial Results

20/03/2018 - 22:05

HALIFAX, Nova Scotia, March 20, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology corporation, today released its financial and operational results for the fiscal [...]

DBV Technologies Annonce le lancement d'une offre globale d'actions ordinaires, pouvant prendre la forme d'American Depositary Shares

20/03/2018 - 22:04

Montrouge, France, le 20 mars 2018, 21h00 CET DBV Technologies Annonce le lancement d'une offre globale d'actions ordinaires, pouvant prendre la forme d'American Depositary Shares DBV Technologies (la « Société ») ( [...]

Galapagos increases share capital through warrant exercises

20/03/2018 - 22:02

Mechelen, Belgium; 20 March 2018, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 298,184 new ordinary [...]

R1 RCM to Begin Trading on the Nasdaq Global Market

20/03/2018 - 22:00

CHICAGO, March 20, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1” or the “Company”) (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced it has [...]